Tag: Cabotegravir

CATALYST Study To Inform National Scale-Up Of PrEP Products in Zimbabwe

Michael Gwarisa

By Michael Gwarisa Following the approval for the use of three Pre-Exposure Prophylaxes (PrEP) products for HIV prevention by the Zimbabwean government,  the country is conducting a three-year study to evaluate and inform the national HIV response’s rollout of PrEP products. The study named CATALYST, which stands for Catalyzing Access to New Prevention Product to Stop HIV is a multi-country study that will characterise and assess the implementation of an enhanced service delivery package providing informed choice of PrEP products among women at the sites where the study is being…

Read More

Zim readies incorporation of Cabotegravir into local PrEP guidelines

Kuda Pembere

FOLLOWING the approval for use of Cabotegravir (CAB-LA) in Zimbabwe by the Medicines Control Authority of Zimbabwe (MCAZ) last year, the country is expected to have incorporated the World Health Organization (WHO) guidelines of this long-acting HIV preventive method into its own HIV pre-exposure prophylaxis in June. By Kudakwashe Pembere That the WHO guidelines would be incorporated into Zimbabwe’s was revealed by renowned HIV Prevention expert Dr Nyaradzo Mgodi last week in a media science café organized by the Health Communicators Forum (HCF). Zimbabwe is the first African country to…

Read More

11 800 Zimbabweans On PrEP

Healthtimes

OVER 11 800 Zimbabweans have been initiated on Pre-Exposure Prophylaxis as of last month, an AVAC fellow said on Monday. By Kudakwashe Pembere Addressing an International AIDS Society Harare Scientific Symposium, AVAC Fellow-cum-Pangaea Aids Zimbabwe Trust coordinator Definate Nhamo said the number was huge. “As of May 2019, we have about 11 800 who have been initiated on on PrEP,” she said. Following the youths demand of PrEP, she said PrEP was only distributed to certain populations perceived to be at risk of contracting HIV. “So in Zimbabwe we started…

Read More